ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Clinical Study Build Programmer - eCOA at Eli Lilly and Company - ApplyBlast

Clinical Study Build Programmer - eCOA

Eli Lilly and Company

27 days ago

4.0 on Glassdoor

Remote

Full Time

Medior

1 applicant

View Job Listing

Apply to 100+ jobs

About this role

The Clinical Study Build Programmer - eCOA is responsible for programming and testing clinical trial data collection databases, including mapping, testing, and normalizing data into a clinical data warehouse. This role requires an in-depth understanding of data technology, standards, and database programming to deliver standardized data collection methods for global clinical trials. The position involves collaborating with Data and Analytics colleagues to ensure accurate and efficient data delivery aligned with study objectives.

Responsibilities

Program and test clinical data collection databases and data warehouse mappings
Configure eCOA/EDC platforms and implement form logic and edit checks
Collaborate with data management colleagues to deliver standardized data collection methods

Skills

Qualifications

Master’s degree in a scientific field such as Informatics/Analytics, Life Sciences, Statistics, Information Technology, Epidemiology, Computer Sciences

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.